Oxford researchers have developed a single-shot malaria vaccine using programmable microcapsules that release booster doses ...

After combining on the development of five malaria vaccine candidates since 2016, Swedish CDMO Recipharm and the University of Oxford have expanded their collaboration to include additional ...

According to the WHO, there were an estimated 249 million cases of malaria worldwide in 2022, resulting in 608,000 deaths.

Why PfSPZ-LARC2 vaccine matters. Malaria remains a devastating disease, responsible for approximately 600,000 deaths and 263 million cases annually, disproportionately affecting Sub-Saharan Africa.

Why PfSPZ-LARC2 Vaccine Matters. Malaria remains a devastating disease, responsible for approximately 600,000 deaths and 263 million cases annually, disproportionately affecting Sub-Saharan Africa.

WASHINGTON (AP) — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...

It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. Stocks with a Value Score from 81 to 100 are considered ...

It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. Stocks with a Value Score from 81 to 100 are considered ...

Beyond cancer, BioNTech is exploring mRNA vaccines for malaria, tuberculosis, and shingles, though most of these programs are still early-stage. It is also partnering with Pfizer on a combined ...

Our technology platform is used in our authorized COVID-19 vaccine and the R21/Matrix-M™ adjuvant malaria vaccine. Novavax cites its Sanofi deal as proving the value of its Matrix-M adjuvant.

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the ...